<p>今天，华尔街分析师重新审视了医疗保健行业的公司 Talkspace。来自 Northland Securities 的分析师 Bobby Brooks 维持了该股票的买入评级，并设定了 5.50 美元的目标价。</p>
<h3>申请 70% 折扣 TipRanks 高级会员</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
<p>Bobby Brooks 给予买入评级的原因是多种因素的结合，这些因素指向 Talkspace 强劲且被低估的增长前景。他强调，Talkspace 在一个庞大且不断增长的心理健康市场中运营，得到了广泛的保险覆盖和最近产品改进的支持，这使得患者更容易注册并保持参与。Brooks 指出，利用率已经开始上升，新的注册人数创下纪录，平均每位被保险成员的会话次数也在上升，他认为这些趋势是当前股价尚未反映的更长增长轨迹的早期证据。</p>
<p>Brooks 还强调了与健康保险门户的更深层次整合的影响，这已经使一个支付方群体转变为 Talkspace 最大的用户群体，显著减少了预约过程中的摩擦。随着计划进行三项额外的门户整合，他预计这种利用率的提升将在更大范围的被覆盖人群中复制。最后，他指出 Talkspace 即将推出的符合 HIPAA 标准、经过临床医生审核的 LLM——基于多年的专有临床数据——是一个尚未在他的财务模型中反映的有意义的增量收入机会，这进一步增强了他对买入评级的信心。</p>
<p>Brooks 覆盖工业部门，专注于 Graham、Tetra Technologies 和 Ceco Environmental 等股票。根据 TipRanks 的数据，Brooks 的平均回报率为 44.7%，推荐股票的成功率为 72.87%。</p>
<p>在 12 月 29 日发布的另一份报告中，Canaccord Genuity 也重申了该股票的买入评级，目标价为 6.00 美元。</p>

TALK

<p>Talkspace 被北方证券的分析师 Bobby Brooks 评级为买入，目标价为 5.50 美元。他指出，强劲的增长前景得益于利用率上升、保险门户的整合以及临床医生审核的 LLM 的推出。Brooks 还提到，注册人数和每次会话的平均值都有所增加，同时与健康保险门户的更深层次整合增强了患者的参与度。Canaccord Genuity 也维持买入评级，目标价为 6.00 美元。Brooks 的股票推荐平均回报率为 44.7%，成功率为 72.87%</p>

<p>Talkspace, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Bobby Brooks from Northland Securities maintained a Buy rating on the stock and has a $5.50 price target.</p>
<div class="lb-trans"><p>今天，华尔街分析师重新审视了医疗保健行业的公司 Talkspace。来自 Northland Securities 的分析师 Bobby Brooks 维持了该股票的买入评级，并设定了 5.50 美元的目标价。</p>
</div><h3>Claim 70% Off TipRanks Premium</h3>
<div class="lb-trans"><h3>申请 70% 折扣 TipRanks 高级会员</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
</div><p>Bobby Brooks has given his Buy rating due to a combination of factors that point to strong, underappreciated growth prospects for Talkspace. He highlights that Talkspace operates in a large and growing mental health market, supported by extensive insurance coverage and recent product improvements that make it easier for patients to enroll and remain engaged. Brooks notes that utilization is already inflecting higher, with record new sign-ups and rising average sessions per insured member, and he views these trends as early evidence of a much longer growth trajectory that the current share price does not yet capture.</p>
<div class="lb-trans"><p>Bobby Brooks 给予买入评级的原因是多种因素的结合，这些因素指向 Talkspace 强劲且被低估的增长前景。他强调，Talkspace 在一个庞大且不断增长的心理健康市场中运营，得到了广泛的保险覆盖和最近产品改进的支持，这使得患者更容易注册并保持参与。Brooks 指出，利用率已经开始上升，新的注册人数创下纪录，平均每位被保险成员的会话次数也在上升，他认为这些趋势是当前股价尚未反映的更长增长轨迹的早期证据。</p>
</div><p>Brooks also emphasizes the impact of deeper integration with health insurance portals, which has already transformed one payor group into Talkspace’s largest cohort by sharply reducing friction in the booking process. With three additional portal integrations planned, he expects this utilization boost to replicate across a larger covered population. Finally, he points to the upcoming launch of Talkspace’s HIPAA-compliant, clinician-reviewed LLM—built on years of proprietary clinical data—as a meaningful incremental revenue opportunity that is not yet reflected in his financial model, reinforcing his conviction in the Buy rating.</p>
<div class="lb-trans"><p>Brooks 还强调了与健康保险门户的更深层次整合的影响，这已经使一个支付方群体转变为 Talkspace 最大的用户群体，显著减少了预约过程中的摩擦。随着计划进行三项额外的门户整合，他预计这种利用率的提升将在更大范围的被覆盖人群中复制。最后，他指出 Talkspace 即将推出的符合 HIPAA 标准、经过临床医生审核的 LLM——基于多年的专有临床数据——是一个尚未在他的财务模型中反映的有意义的增量收入机会，这进一步增强了他对买入评级的信心。</p>
</div><p>Brooks covers the Industrials sector, focusing on stocks such as Graham, Tetra Technologies, and Ceco Environmental. According to TipRanks, Brooks has an average return of 44.7% and a 72.87% success rate on recommended stocks.</p>
<div class="lb-trans"><p>Brooks 覆盖工业部门，专注于 Graham、Tetra Technologies 和 Ceco Environmental 等股票。根据 TipRanks 的数据，Brooks 的平均回报率为 44.7%，推荐股票的成功率为 72.87%。</p>
</div><p>In another report released on December 29, Canaccord Genuity also reiterated a Buy rating on the stock with a $6.00 price target.</p>
<div class="lb-trans"><p>在 12 月 29 日发布的另一份报告中，Canaccord Genuity 也重申了该股票的买入评级，目标价为 6.00 美元。</p>
</div>

Talkspace 未来的增长潜力被低估，这主要得益于使用率的上升、保险门户的整合以及临床医生审核的 LLM 的推出